LifeStance officer proposes $8.47M share sale
The notice lists Merrill Lynch Pierce Fenner & Smith as broker and 380,190,724 common shares outstanding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. (LFST) officer Ryan Pardo reported a proposed sale of 587,920 common shares; the remarks identify the shares as sales from the Pardo Family Rev Trust. The securities information lists an aggregate market value of $8,466,048 and an approximate sale date of November 10, 2026. It gives August 11, 2026, as the Rule 10b5-1 plan adoption or instruction date.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.